Table 2 Functions and diseases related to both CEU and YRI signatures
| Â | CEU | YRI |
|---|---|---|
Diabetes | 1.70E-17 | 2.70E-20 |
Coronary artery disease | 3.78E-17 | 3.12E-13 |
Genetic disorder | 1.09E-14 | 4.53E-14 |
Cardiovascular disease | 1.34E-14 | 4.78E-11 |
Non-insulin-dependent diabetes mellitus | 1.03E-12 | 8.66E-15 |
Endocrine system disorder | 1.91E-12 | 1.25E-18 |
Hypertension | 2.13E-12 | 2.83E-11 |
Neurological disorder | 2.49E-12 | 3.27E-12 |
Crohn's disease | 7.59E-12 | 7.25E-09 |
Bipolar affective disease | 3.50E-11 | 5.24E-09 |
Metabolic disorder | 5.66E-11 | 9.83E-16 |
Inflammatory disorder | 2.56E-09 | 1.08E-08 |
Digestive system disorder | 2.66E-09 | 1.31E-07 |
Skeletal and muscular disorder | 1.49E-08 | 1.58E-08 |
Progressive motor neuropathy | 2.53E-08 | 5.59E-12 |
Autoimmune disease | 7.28E-08 | 1.09E-12 |
Immunological disorder | 2.46E-07 | 3.66E-13 |
Rheumatoid arthritis | 3.78E-07 | 2.54E-07 |
Shape change of epithelial cells | 8.86E-07 | Â |
Alzheimer's disease | 3.60E-06 | 2.27E-07 |
Parkinson's disease | 7.24E-06 | 5.29E-06 |
Shape change of dermal cells | 9.33E-06 | Â |
Insulin-dependent diabetes mellitus | Â | 3.76E-15 |
Neuropathy | Â | 5.38E-12 |
Amyotrophic lateral sclerosis | Â | 1.36E-09 |
Arthritis | Â | 1.44E-07 |